299
Participants
Start Date
March 18, 2024
Primary Completion Date
September 19, 2025
Study Completion Date
October 13, 2025
NNC0519-0130
NNC0519-0130 will be administered subcutaneously.
Placebo
Placebo will be administered subcutaneously.
Trizepatide
Trizepatide will be administered subcutaneously.
Royal North Shore Hospital, St Leonards
Macquarie University, Macquarie Park
Western Endocrine Blacktown, Sydney
Illawarra Diabetes Service Clinical Trials & Research Unit, Wollongong
The Royal Melbourne Hospital, Parkville
Austin Health, Metabolic Disorders Centre, Heidelberg Heights
Emeritus Research Melbourne, Camberwell
Eastern Clinical Research Unit Box Hill, Box Hill
University of Sunshine Coast, Birtinya
Seoul National University Bundang Hospital, Gyeonggi-do
Velocity Clinical Research Binghamton, Binghamton
Preferred Primary Care Physicians Inc., Pittsburgh
Preferred Primary Care Physicians, Inc., Uniontown
MD Medical Research, Oxon Hill
Centennial Medical Group, Columbia
Burke Internal Medicine & Research, Burke
TPMG Clinical Research, Newport News
PharmQuest Life Sciences LLC, Greensboro
Accellacare Wilmington, Wilmington
Centricity Research, Columbus
International Research Associates, LLC_Miami, Miami
Innovative Research of W Florida Inc., Clearwater
Innovative Research of W FL, Clearwater
Advanced Med Res Maumee, Maumee
Diab & Endo Assoc of Stark Co, Canton
Velocity Clin Res_Cincinnati, Cincinnati
Velocity Clinical Research Springdale, Cincinnati
Providence Health Partners Ctr, Dayton
Mercury Str Med Grp, PLLC, Butte
Methodist Medical Center of Illinois, Peoria
Clinvest Research, Springfield
Tekton Research, Irving
Epic Clinical Research, Lewisville
Care United Research, LLC, Forney
Velocity Clinical Res-Dallas, Dallas
Zenos Clinical research, Dallas
Biopharma Informatic_Houston, Houston
Consano Clinical Research, LLC, Shavano Park
Velocity Clin Res Austin, Austin
Velocity Clinical Research Abilene, Abilene
University of Colorado Hospital, Aurora
Elite Clinical Trials, Blackfoot
Excel Clinical Network, Las Vegas
Palm Research Center Inc-Vegas, Las Vegas
310 Clinical Research, Inglewood
Torrance Clin Res Inst, Inc., Lomita
Pacific Clinical Studies, Los Alamitos
Med Partners, Inc., Toluca Lake
Catalina Research Institute, LLC, Montclair
Velocity Clin Res-Chula Vista, Chula Vista
Velocity Clin Res San Diego, La Mesa
University Clin Investigators, Tustin
First Valley Med Grp Lancaster, Lancaster
Valley Research, Fresno
Diablo Clinical Research, Inc., Walnut Creek
Diabetes, Thyroid and Endocrine Centre, Jaipur
Seth GS Medical College & KEM Hospital, Mumbai
Chellaram Diabetes Institute, Pune
Diabetes Research Center, Hyderabad, Hyderabad
MS Ramaiah, Bengaluru
Life Care Hospital and Research Centre, Bangalore
Christian Medical College Hospital, Vellore, Vellore
Amrita Institute Of Medical Sciences & Research Centre, Kochi
OCT Research ULC (dba Okanagan Clinical Trials), Kelowna
OCT Research ULC (dba Okanagan Clinical Trials), Richmond
Cook Street Medical Clinic, Victoria
G.A. Research Associates Ltd., Moncton
Nova Scotia Hlth Halifax, Halifax
Wharton Med Clin Trials, Hamilton
Albion Finch Medical Centre, Toronto
Centricity Research Quebec City, Lévis
Recherche GCP Research, Montreal
Diex Recherche Quebec Inc., Québec
Tokuyama clinic_Diabetic internal medicine, Chiba
Soka Sugiura Internal Medicine Clinic, Soka-shi, Saitama
Tokyo-Eki Center-building Clinic_Internal Medicine, Tokyo
Fukuwa Clinic_Internal Medicine, Tokyo
Fukuwa Clinic, Tokyo
Nowon Eulji Medical Center, Eulji University, Seoul
Korea University Anam Hospital, Seoul
Kangbuk Samsung Hospital, Seoul
Asan Medical Center, Seoul
Lead Sponsor
Novo Nordisk A/S
INDUSTRY